Locanabio, Inc.
Creating RNA-targeting gene therapies to treat devastating diseases
7 employees · est. 2016 · San Diego, United States
Precede Biosciences
Precede Bio is impacting precision medicine with a first-in-class 🩸 liquid biopsy platform
61 employees · est. 2021 · United States
Locanabio, Inc. is the older company (2016 vs 2021); Precede Biosciences is the larger of the two.
Side-by-Side Comparison
| Metric | Locanabio, Inc. | Precede Biosciences |
|---|---|---|
| Founded | ||
| Founded | 2016 older | 2021 |
| Headquarters | ||
| Headquarters | San Diego, United States | United States |
| Employees | ||
| Employees | 7 | 61 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Not tracked yet |
| Funding Stage | ||
| Funding Stage | Series B | Series A |
| Total Funding | ||
| Total Funding | $155.55M | $120.50M |
| Funding Rounds | ||
| Funding Rounds | 3 | 2 |
| Services | ||
| Services | Not tracked yet | Liquid biopsy platform development, Epigenomic analysis and profiling, Diagnostics for cancer and other diseases, Therapeutic target identification, Strategic partnerships with pharmaceutical companies, R&D in precision medicine |
| Target Customers | ||
| Target Customers | Not tracked yet | Pharmaceutical companies, Biotech firms, Oncology research institutions, Healthcare providers, Medical diagnostic labs |
| Taxonomy | ||
| Taxonomy | RNA-targeting Gene Therapy, Genetic Medicine, Neurodegenerative Diseases, Neuromuscular Diseases, Rare Genetic Diseases, RNA Biology, Gene Editing, Genomic Medicine, RNA-mediated Disease, Drug Development, Neurological Disorders | Precision Medicine, Liquid Biopsy, Transcriptional Biology, Chromatin Profiling, DNA Methylome, Genomic Medicine, Diagnostic Tests, Drug Development, Cancer Diagnosis, Minimally Invasive Diagnostics, Disease Biology, Machine Learning In Genomics, Artificial Intelligence In Healthcare, Oncology, Genomic Profiling |
| Website | ||
| Website | locanabio.com | precede.bio |
About Locanabio, Inc.
Locanabio, Inc., founded in 2016, is at the forefront of developing RNA-targeting gene therapies to address significant unmet medical needs. Their innovative approach focuses on correcting disease-causing RNA, utilizing a proprietary platform that includes advanced systems like snRNA, Cas13d, and PU...
About Precede Biosciences
Precede Biosciences, founded in 2021, is at the forefront of precision medicine with its innovative first-in-class liquid biopsy platform. With headquarters in the United States, the company stands out for its commitment to enhance the medical community's understanding of disease-defining biology, o...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Locanabio, Inc. and Precede Biosciences — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Locanabio, Inc. and Precede Biosciences — by email.
Frequently Asked Questions
Compare Locanabio, Inc. with someone else
Start typing a company name or domain.